By Hendra Lukman 
Research published in 2025 found that taking vitamin D2 can reduce levels of vitamin D3, the form humans naturally make when skin is exposed to sunlight. This discovery challenges the long-held assumption that vitamin D2 and vitamin D3 are interchangeable and highlights the need for a more nuanced understanding of vitamin D supplementation for public health.
Vitamin D: An Essential Nutrient with Complex Forms
Vitamin D is a fat-soluble vitamin crucial for numerous bodily functions, most notably its role in calcium absorption, which is vital for maintaining strong bones and preventing conditions like rickets in children and osteoporosis in adults. Beyond bone health, vitamin D plays a significant role in immune system regulation, muscle function, and cellular growth. Its deficiency has been linked to a higher risk of various chronic diseases, including certain cancers, cardiovascular disease, and autoimmune disorders.
The body can synthesize vitamin D when the skin is exposed to ultraviolet B (UVB) radiation from sunlight. This naturally produced form is vitamin D3, also known as cholecalciferol. However, in many parts of the world, particularly during winter months or for individuals with limited sun exposure due to lifestyle or geographical location, dietary intake and supplementation become essential.
Vitamin D supplements typically come in two primary forms: vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol). Vitamin D2 is primarily derived from plant and fungal sources, such as mushrooms exposed to UV light, and is often found in fortified foods and some prescription supplements. Vitamin D3, on the other hand, is produced in the skin upon sun exposure and is also commonly sourced from lanolin (sheep’s wool) for dietary supplements, though vegan and plant-based D3 options derived from lichen are increasingly available.
For decades, these two forms were largely considered equivalent in their ability to raise overall vitamin D levels in the body. Both are converted in the liver to 25-hydroxyvitamin D, the primary indicator of vitamin D status measured in blood tests. However, a growing body of scientific evidence, culminating in significant findings from research published in 2025, suggests that this equivalence is not entirely accurate, particularly concerning the efficacy and metabolic pathways of each form.
Landmark 2025 Study Reveals D2’s Impact on D3 Levels
A pivotal study published in the peer-reviewed journal Nutrition Reviews in 2025, a collaborative effort by researchers from the University of Surrey, the John Innes Centre, and Quadram Institute Bioscience, has shed new light on the complex relationship between vitamin D2 and D3. This comprehensive meta-analysis pooled data from 20 randomized controlled trials, with 11 trials providing sufficient data for robust statistical analysis. The research aimed to investigate the potential differential effects of vitamin D2 supplementation on vitamin D3 levels.
The findings were striking: individuals who received vitamin D2 supplementation exhibited significantly lower concentrations of 25-hydroxyvitamin D3, the metabolite derived from vitamin D3. The average reduction observed, depending on the analytical approach, ranged from approximately 9 to 18 nanomoles per liter. This discovery represents a previously unrecognized interaction, suggesting that an increase in vitamin D2 intake may lead to a decrease in the body’s naturally produced or D3-supplemented vitamin D3 levels.
It is crucial to emphasize that this finding does not imply that vitamin D2 actively removes vitamin D from the body or that its consumption is inherently harmful. Vitamin D2 still effectively raises the levels of 25-hydroxyvitamin D2 and contributes to the total vitamin D status. The surprise lies in the observed inverse relationship, where the increase of one form appears to be correlated with a reduction in the other.
Dr. Emily Brown, PhD Research Fellow and Lead Researcher from the University of Surrey’s Nutrition, Exercise, Chronobiology & Sleep Discipline, articulated the significance of these findings. "Vitamin D supplements are important, especially between October and March, when our bodies cannot make vitamin D from sunlight in the UK," Dr. Brown stated. "However, we discovered that vitamin D2 supplements can actually decrease levels of vitamin D3 in the body, which is a previously unknown effect of taking these supplements. This study suggests that, subject to personal considerations, vitamin D3 supplements may be more beneficial for most individuals over vitamin D2."
Unraveling the Mechanism: Why Does D2 Affect D3?
The precise biological mechanism behind this observed reduction in vitamin D3 levels due to vitamin D2 supplementation remains an area of active investigation. Scientists are exploring several hypotheses to explain this phenomenon.
One leading theory posits that the body possesses intricate regulatory mechanisms for vitamin D metabolism. When the concentrations of vitamin D metabolites rise, the body may initiate a process of accelerated breakdown and excretion to maintain homeostasis. Researchers have proposed that an elevated intake of vitamin D2 could potentially trigger an increased disposal rate of existing 25-hydroxyvitamin D3, thereby leading to lower circulating levels.
Further complicating the picture, earlier experimental research has hinted at a bidirectional relationship. Some studies have suggested that vitamin D3 supplementation can, in certain contexts, lead to a reduction in vitamin D2-derived metabolites. This suggests a complex interplay and balancing act within the body’s vitamin D processing pathways. The ultimate clinical significance of this observed balancing effect on overall health outcomes is still a subject of ongoing research.
Professor Cathie Martin, Group Leader at the John Innes Centre, highlighted the implications of this research for dietary choices, particularly for those following plant-based diets. "This meta-analysis highlights the importance of ensuring plant-based vitamin D3 is accessible in the UK," Professor Martin commented. The increasing availability of plant-based and animal-free sources of vitamin D3, such as those derived from lichen, addresses a critical need for accessible and effective vitamin D options for a growing segment of the population.
Beyond Levels: Differential Effects on the Immune System
The implications of the 2025 study extend beyond mere quantitative differences in vitamin D metabolites. Emerging research suggests that vitamin D2 and D3 might exert distinct effects on cellular and physiological processes, even when their overall impact on vitamin D status is comparable.
A study published in Frontiers in Immunology, led by Professor Colin Smith from the University of Surrey, explored how different vitamin D supplementation forms influenced gene activity in blood cells. This research revealed substantial variations in the cellular responses to vitamin D2 versus vitamin D3. Notably, vitamin D3 appeared to stimulate activity associated with type I interferon signaling, a crucial component of the innate immune system. Vitamin D2, however, did not elicit the same response.
Type I interferons are signaling proteins that play a vital role in the body’s initial defense against viral and bacterial infections. They act as alarm signals, alerting cells to the presence of pathogens and initiating antiviral and antimicrobial responses.
Professor Colin Smith explained the potential significance of these immune-related findings: "We have shown that vitamin D3, but not vitamin D2, appears to stimulate the type I interferon signaling system in the body — a key part of the immune system that provides a first line of defense against bacteria and viruses. Thus, a healthy vitamin D3 status may help prevent viruses and bacteria from gaining a foothold in the body."
While these immune system findings are scientifically intriguing and point towards a potential functional advantage of vitamin D3, it is important to exercise caution in their interpretation. Changes in gene activity and immune signaling do not automatically translate into a direct reduction in illness frequency or severity. Larger, more extensive clinical trials are necessary to definitively ascertain the real-world health implications of these observed differences in immune system modulation.
Nuances Emerge: D2’s Continued Biological Relevance
Subsequent research, published in 2026, has introduced further nuance to the understanding of vitamin D2 and D3. A separate systematic review and meta-analysis examined 26 randomized trials specifically focused on vitamin D2 supplementation. This comprehensive review confirmed that vitamin D2 supplementation continues to have meaningful biological effects. It was found to significantly reduce parathyroid hormone levels and induce a modest increase in blood calcium. These effects are important indicators of vitamin D’s role in calcium homeostasis and bone health, demonstrating that D2 is not biologically inert, even if it may reduce circulating D3.
This recent finding is critical because it clarifies that the observed reduction in D3 levels does not equate to vitamin D2 being ineffective. Current guidance from health authorities, such as the U.S. National Institutes of Health (NIH), continues to acknowledge that both D2 and D3 can raise overall blood vitamin D levels. The distinction, as highlighted by the accumulating evidence, lies in the magnitude and duration of this increase, with D3 generally demonstrating superior efficacy in raising and sustaining blood vitamin D concentrations for longer periods.
This conclusion is consistent with previous meta-analyses that directly compared the two forms. For instance, one analysis involving 24 studies found vitamin D3 to be more effective than D2 in improving overall vitamin D status. Another study that focused on frequent dosing regimens reached a similar consensus, reinforcing the notion that D3 may offer a more potent and sustained benefit.
The Unanswered Question: Clinical Significance of D2 vs. D3
Despite the growing body of evidence, a central question remains unanswered: what are the tangible health consequences of the observed differences between vitamin D2 and D3, particularly the reduction of D3 levels by D2? While randomized controlled trials strongly suggest that D2 can indeed reduce circulating D3, the clinical significance of this reduction for long-term health outcomes is still under investigation.
Researchers are calling for further in-depth studies to elucidate the precise metabolic pathways of both vitamin D forms. Understanding how they are processed, whether their differential effects on immune function translate into meaningful health benefits or risks, and whether vitamin D3 should be unequivocally recommended as the preferred form for routine supplementation in the absence of specific contraindications for D2, are key areas for future research.
Professor Martin Warren, Chief Scientific Officer at the Quadram Institute, emphasized the public health imperative behind this line of inquiry. "Vitamin D deficiency represents a significant public health concern, especially during the winter months with significant deficiency across the UK population," Professor Warren stated. "This collaborative research effort aligns well with the Quadram Institute’s mission to deliver healthier lives through food innovation to enhance the nutrient density of the food we eat. Tackling this with the most effective form of vitamin D supplementation or fortification is of the utmost importance to the health of the nation."
Implications for Public Health and Supplement Choices
The evolving scientific landscape surrounding vitamin D supplementation carries significant implications for public health policy and individual consumer choices. The evidence increasingly suggests that the form of vitamin D listed on a supplement label is not a trivial detail. While both D2 and D3 contribute to the body’s vitamin D status, their metabolic behaviors appear to differ, with vitamin D3 exhibiting a more favorable profile for raising and maintaining optimal blood levels.
The critical next step for the scientific community is to bridge the gap between biochemical differences and observable health outcomes. Establishing whether these metabolic distinctions translate into clinically relevant differences in disease prevention, immune response, or overall well-being will be crucial in guiding future recommendations. Until such definitive evidence emerges, the current scientific consensus leans towards vitamin D3 as potentially the more advantageous choice for routine supplementation, particularly for individuals seeking to maximize and sustain their vitamin D levels. As research continues to deepen our understanding, consumers are encouraged to stay informed and consult with healthcare professionals regarding their specific vitamin D needs.
